Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphomannomutase 2 pseudogene 1 (PMM2P1) is a nonfunctional, processed pseudogene located on chromosome 18p in the human genome. It arose by duplication from the active gene phosphomannomutase 2 (PMM2) and retains high sequence similarity to PMM2 but does not produce a functional protein or participate in any known biological pathways. Several mutations found in the disease-associated PMM2 gene are also present in PMM2P1, reflecting its close evolutionary history. No diseases have been associated with defects in PMM2P1, nor is it relevant as a therapeutic target, biomarker, or drug interaction partner. If a query refers to PMM2P1 as a target, it is incorrect: the functional, disease-relevant target is PMM2 (phosphomannomutase 2).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphomannomutase 2 pseudogene 1 (PMM2P1).